$22M sweet spot round size
Most of their 221 investments are in rounds between $11M and $35M
1993
Therini Bio, Inc. (formerly MedaRed, Inc.) raised $36M on April 27, 2023
Investors: Sanofi Ventures, The Dementia Discovery Fund, Dolby Family Ventures and SV Life Sciences
PayMedix raised $25M on January 25, 2023
Investors: Hexagon AB and SV Life Sciences
PULMOCIDE LIMITED raised $52M on December 6, 2022
Investors: 旭化成ファーマ(株), Vivo Capital, JEITO, F-Prime Capital Partners, S.R. One Ltd, Longwood Fund, IP Group plc and SV Life Sciences
Alpheus Medical, Inc raised $14M on November 10, 2022
Investors: OrbiMed Advisors, Medtech Convergence Fund and SV Life Sciences
Undisclosed raised $125M on September 12, 2022
Investors: S.R. One Ltd, Lightstone Ventures, RA Capital Management, L.P., Atlas Venture and SV Life Sciences
Undisclosed raised $18M on June 29, 2022
Investors: IndieBio, SOSV - The Accelerator VC, Baring Private Equity Asia and SV Life Sciences
viTToria biotherapeutics raised $10M on June 7, 2022
Investors: Tellus BioVentures, Agent Capital and SV Life Sciences
Rondo Therapeutics raised $67M on March 2, 2022
Investors: Novo Holdings, Red Tree Venture Capital and SV Life Sciences
Perfuze raised $26M on February 9, 2022
Investors: Seroba-Kernel Ltd (Ireland), EarlyBird Snacks, EQT Life Sciences, Enterprise Ireland and SV Life Sciences
Quell Therapeutics raised $156M on November 29, 2021
Investors: Tekla Capital Management, Syncona Limited, Monashee Investment Management LLC, JEITO, British Patient Capital, Ridgeback Capital Management LLC, Point72 Asset Management and SV Life Sciences
SV Life Sciences raised undisclosed on December 20, 2018
Investors: SV Life Sciences